A. İNAL Et Al. , "Bioequivalence study of eltrombopag 75 mg film-coated tablets under fasting conditions during the Covid-19 pandemic in healthy Caucasian male subjects," BMC Pharmacology and Toxicology , vol.25, no.1, 2024
İNAL, A. Et Al. 2024. Bioequivalence study of eltrombopag 75 mg film-coated tablets under fasting conditions during the Covid-19 pandemic in healthy Caucasian male subjects. BMC Pharmacology and Toxicology , vol.25, no.1 .
İNAL, A., SEZER, Z., Pinarbasli, O., Bulut, B., Reinsch, M., Martin, W., ... MAZICIOĞLU, M. M.(2024). Bioequivalence study of eltrombopag 75 mg film-coated tablets under fasting conditions during the Covid-19 pandemic in healthy Caucasian male subjects. BMC Pharmacology and Toxicology , vol.25, no.1.
İNAL, AHMET Et Al. "Bioequivalence study of eltrombopag 75 mg film-coated tablets under fasting conditions during the Covid-19 pandemic in healthy Caucasian male subjects," BMC Pharmacology and Toxicology , vol.25, no.1, 2024
İNAL, AHMET Et Al. "Bioequivalence study of eltrombopag 75 mg film-coated tablets under fasting conditions during the Covid-19 pandemic in healthy Caucasian male subjects." BMC Pharmacology and Toxicology , vol.25, no.1, 2024
İNAL, A. Et Al. (2024) . "Bioequivalence study of eltrombopag 75 mg film-coated tablets under fasting conditions during the Covid-19 pandemic in healthy Caucasian male subjects." BMC Pharmacology and Toxicology , vol.25, no.1.
@article{article, author={AHMET İNAL Et Al. }, title={Bioequivalence study of eltrombopag 75 mg film-coated tablets under fasting conditions during the Covid-19 pandemic in healthy Caucasian male subjects}, journal={BMC Pharmacology and Toxicology}, year=2024}